How many 8-K filings has Protalix Biotherapeutics, Inc. filed?

Protalix Biotherapeutics, Inc. (PLX) has 11 8-K (Current Event Report) filings on record, spanning Jun 2024 to Nov 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Protalix Biotherapeutics, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Protalix Biotherapeutics, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Protalix Biotherapeutics, Inc. (PLX) — 8-K Filings

All 8-K filings from Protalix Biotherapeutics, Inc.. Browse 11 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (11)

Protalix BioTherapeutics Files 8-K — Nov 3, 2025 Risk: low
Protalix BioTherapeutics, Inc. filed an 8-K on November 3, 2025, reporting on other events and financial statements. The filing does not contain specific financ
Protalix BioTherapeutics Files 8-K — Oct 17, 2025 Risk: low
On October 17, 2025, Protalix BioTherapeutics, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other event
Protalix BioTherapeutics Files 8-K: Material Agreement & Exhibits — Aug 22, 2025 Risk: medium
On August 22, 2025, Protalix BioTherapeutics, Inc. filed an 8-K report. The filing indicates an entry into a material definitive agreement and includes financia
Protalix BioTherapeutics Files 8-K Report — Aug 1, 2025 Risk: low
On August 1, 2025, Protalix BioTherapeutics, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific detail
Protalix BioTherapeutics Files 8-K on Key Corporate Events — Jul 21, 2025 Risk: low
Protalix BioTherapeutics, Inc. filed an 8-K on July 21, 2025, reporting events that occurred on June 13, 2025. The filing includes information on a material def
Protalix BioTherapeutics Files 8-K on Shareholder Vote Matters — Jun 26, 2025 Risk: low
On June 26, 2025, Protalix BioTherapeutics, Inc. filed an 8-K report indicating a submission of matters to a vote of security holders. The company, incorporated
Protalix BioTherapeutics Files 8-K on Officer/Director Changes — Apr 23, 2025 Risk: medium
Protalix BioTherapeutics, Inc. filed an 8-K on April 23, 2025, reporting on the departure of directors or certain officers, election of directors, appointment o
Protalix BioTherapeutics Files 8-K on Security Holder Rights — Dec 31, 2024 Risk: medium
Protalix BioTherapeutics, Inc. filed an 8-K on December 31, 2024, reporting events that occurred on December 27, 2024. The filing indicates material modificatio
Protalix BioTherapeutics Files 8-K — Dec 23, 2024 Risk: low
Protalix BioTherapeutics, Inc. filed an 8-K on December 23, 2024, reporting information under Regulation FD and including financial statements and exhibits. The
Protalix BioTherapeutics Files 8-K — Oct 25, 2024 Risk: low
On October 25, 2024, Protalix BioTherapeutics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the submission of Financial
Protalix BioTherapeutics Files 8-K on Shareholder Vote Matters — Jun 28, 2024 Risk: low
On June 27, 2024, Protalix BioTherapeutics, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing also incl

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX